Celecoxib decreases prostaglandin E(2 )concentrations in nipple aspirate fluid from high risk postmenopausal women and women with breast cancer

BACKGROUND: Celecoxib inhibits PGE2 production in cancerous tissue. We previously reported that PGE2 levels in nipple aspirate fluid (NAF) and plasma were not decreased in women at increased breast cancer risk who received celecoxib 200 mg twice daily (bid). The endpoints of the current study were t...

Descripción completa

Detalles Bibliográficos
Autores principales: Sauter, Edward R, Qin, Wenyi, Schlatter, Lisa, Hewett, John E, Flynn, John T
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1621075/
https://www.ncbi.nlm.nih.gov/pubmed/17049084
http://dx.doi.org/10.1186/1471-2407-6-248

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1621075/
https://www.ncbi.nlm.nih.gov/pubmed/17049084
http://dx.doi.org/10.1186/1471-2407-6-248

Ejemplares similares